Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $68.00 (-0.8%) * Over Last 12-Mos
Rating Score: 3.6 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/4/2015 Piper Jaffray Downgrade Neutral
(Overweight)
68.00
(81.00)
64.70 68.56 5.97% Details
9/26/2014 Leerink Swann New Coverage Market Perform
(N/A)
40.00
(N/A)
40.30 68.56 70.12% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, GSK

ISIS Ratings News